Literature DB >> 19244625

Determinants of stability for the E6 protein of papillomavirus type 16.

Yuqi Liu1, Jonathan J Cherry, Joseph V Dineen, Elliot J Androphy, James D Baleja.   

Abstract

E6 is an oncoprotein produced by human papillomavirus (HPV). The E6 protein from high-risk HPV type 16 contains two zinc-binding domains with two C-x-x-C motifs each. E6 exerts its transforming functions through formation of a complex with E6AP, which binds p53 and stimulates its degradation. There have been few biophysical and structural studies due to difficulty in preparation of soluble protein; here we describe the preparation of soluble E6 constructs including the two separated zinc-binding domains of E6. These proteins are used to examine the extent to which the two domains cooperate to mediate E6 function, how zinc influences the behavior of E6 protein, and which domains mediate aggregation. We demonstrate, using p53 degradation, E6AP binding, and hDlg (human homolog of the Drosophila discs large tumor suppressor protein) PDZ (postsynaptic density/disc large/zonula occludens) protein binding assays, that these soluble proteins are active, and, using NMR, circular dichroism, and fluorescence spectroscopies, we show that they are folded and stable. We show that the separated N-terminal and C-terminal domains interact, but nonproductively, for E6 function. The two domains bind zinc differently with higher affinity associated with the C-terminal domain. Analyses using surface plasmon resonance and circular dichroism and fluorescence spectroscopies show that aggregation is mediated more through the N-terminal domain than through the C-terminal domain. These studies allow a model in which the C-terminal zinc-binding domain of E6 recruits a target protein such as hDlg and the N-terminal domain is mostly responsible for recruiting a ubiquitin ligase to mediate target protein degradation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244625      PMCID: PMC2768073          DOI: 10.1016/j.jmb.2009.01.018

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

Review 1.  Enhancement of soluble protein expression through the use of fusion tags.

Authors:  Dominic Esposito; Deb K Chatterjee
Journal:  Curr Opin Biotechnol       Date:  2006-06-15       Impact factor: 9.740

2.  High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.

Authors:  María M García-Alai; Karina I Dantur; Clara Smal; Lía Pietrasanta; Gonzalo de Prat-Gay
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

3.  1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6.

Authors:  Yves Nominé; Sebastian Charbonnier; Laurent Miguet; Noelle Potier; Alain Van Dorsselaer; R Andrew Atkinson; Gilles Travé; Bruno Kieffer
Journal:  J Biomol NMR       Date:  2005-02       Impact factor: 2.835

4.  Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.

Authors:  Yi Zhang; Jhimli Dasgupta; Runlin Z Ma; Lawrence Banks; Miranda Thomas; Xiaojiang S Chen
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.

Authors:  Katia Zanier; Sebastian Charbonnier; Mireille Baltzinger; Yves Nominé; Danièle Altschuh; Gilles Travé
Journal:  J Mol Biol       Date:  2005-04-09       Impact factor: 5.469

6.  Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.

Authors:  Yuqi Liu; Gillian D Henry; Rashmi S Hegde; James D Baleja
Journal:  Biochemistry       Date:  2007-08-22       Impact factor: 3.162

Review 7.  Papillomavirus E6 and E7 proteins and their cellular targets.

Authors:  Trisha M Wise-Draper; Susanne I Wells
Journal:  Front Biosci       Date:  2008-01-01

Review 8.  Structure and function of the papillomavirus E6 protein and its interacting proteins.

Authors:  Yuqi Liu; James D Baleja
Journal:  Front Biosci       Date:  2008-01-01

9.  Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells.

Authors:  William C Spanos; Jeremy Geiger; Mary E Anderson; George F Harris; Aaron D Bossler; Russell B Smith; Aloysius J Klingelhutz; John H Lee
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

Review 10.  Cellular binding partners of the human papillomavirus E6 protein.

Authors:  Sandy S Tungteakkhun; Penelope J Duerksen-Hughes
Journal:  Arch Virol       Date:  2008-01-03       Impact factor: 2.574

View more
  15 in total

Review 1.  Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma.

Authors:  Daniel L Miller; Michael D Puricelli; M Sharon Stack
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

2.  Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97.

Authors:  Celestine N Chi; Anders Bach; Åke Engström; Kristian Strømgaard; Patrik Lundström; Neil Ferguson; Per Jemth
Journal:  J Biol Chem       Date:  2010-11-27       Impact factor: 5.157

3.  Construction and identification of a yeast two-hybrid bait vector and its effect on the growth of yeast cells and the self-activating function of reporter genes for screening of HPV18 E6-interacting protein.

Authors:  Quan Mei; Shuang Li; Ping Liu; Ling Xi; Shixuan Wang; Yuhan Meng; Jie Liu; Xinwei Yang; Yunping Lu; Hui Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

4.  Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

Authors:  Katia Zanier; Abdellahi ould M'hamed ould Sidi; Charlotte Boulade-Ladame; Vladimir Rybin; Anne Chappelle; Andrew Atkinson; Bruno Kieffer; Gilles Travé
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

5.  Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

Authors:  Abdellahi Ould M'hamed Ould Sidi; Khaled Ould Babah; Nicole Brimer; Yves Nominé; Christophe Romier; Bruno Kieffer; Scott Vande Pol; Gilles Travé; Katia Zanier
Journal:  Protein Expr Purif       Date:  2011-07-14       Impact factor: 1.650

6.  Genetic analysis of human papilloma virus 16 E6/E7 variants obtained from cervical cancer cases in Chhattisgarh, a central state of India.

Authors:  Sanjay Singh Negi; Kuldeep Sharma; Divakar Sharma; Pushpendra Singh; Pragya Agarwala; Nighat Hussain; Anudita Bhargava; Padma Das; Sarita Agarwal
Journal:  Virusdisease       Date:  2021-07-26

7.  Overcoming the solubility limit with solubility-enhancement tags: successful applications in biomolecular NMR studies.

Authors:  Pei Zhou; Gerhard Wagner
Journal:  J Biomol NMR       Date:  2010-01       Impact factor: 2.835

8.  E6 proteins from diverse papillomaviruses self-associate both in vitro and in vivo.

Authors:  Katia Zanier; Christine Ruhlmann; Frederic Melin; Murielle Masson; Abdellahi Ould M'hamed Ould Sidi; Xavier Bernard; Benoit Fischer; Laurent Brino; Tutik Ristriani; Vladimir Rybin; Mireille Baltzinger; Scott Vande Pol; Petra Hellwig; Patrick Schultz; Gilles Travé
Journal:  J Mol Biol       Date:  2009-11-13       Impact factor: 5.469

9.  The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.

Authors:  Virginia P Ronchi; Jennifer M Klein; Daniel J Edwards; Arthur L Haas
Journal:  J Biol Chem       Date:  2013-11-22       Impact factor: 5.157

10.  Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.

Authors:  André Mischo; Oliver Ohlenschläger; Peter Hortschansky; Ramadurai Ramachandran; Matthias Görlach
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.